References
Delvecchio M, Mozzillo E, Salzano G et al (2017) Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED). Monogenic diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes centers during 2007 to 2012. J Clin Endocrinol Metab 102:1826–1834
Shepherd M, Shields B, Hammersley S et al (2016) Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the U.K. pediatric diabetes population with monogenic diabetes. Diabetes Care 39:1879–1888
Shields BM, Shepherd M, Hudson M et al (2017) Population-based assessment of a biomarker-based screening pathway to aid diagnosis of monogenic diabetes in young-onset patients. Diabetes Care 40:1017–1025
Stride A, Vaxillaire M, Tuomi T et al (2002) The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 45:427–435
Pinelli M, Acquaviva F, Barbetti F et al (2013) Identification of candidate children for Maturity Onset Daiabetes of the Young type 2 (MODY 2) genetic testing: a seven item clinical flow-chart. PLoS One 8:e79933
Author information
Authors and Affiliations
Consortia
Contributions
All Authors and contributors researched data and critically reviewed the paper. MD collected data, performed statistics and drafted the paper. AN performed statistics. FB, the guarantor of the paper, conceived the study, collected data, and critically revised the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
Authors have no conflict of interest to declare.
Human and animal rights
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committe and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Fot this type of study formal consent is not required.
Additional information
Managed by Massimo Porta.
Rights and permissions
About this article
Cite this article
Delvecchio, M., Salzano, G., Bonura, C. et al. Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?. Acta Diabetol 55, 981–983 (2018). https://doi.org/10.1007/s00592-018-1179-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-018-1179-y